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Abstract
Background: Defensins are antimicrobial peptides of innate immunity functioning by non-specific
binding to anionic phospholipids in bacterial membranes. Their cationicity, amphipathicity and
ability to oligomerize are considered key factors for their action. Based on structural information
on human β-defensin 2, we examine homologous defensins from various mammalian species for
conserved functional physico-chemical characteristics.
Results: Based on homology greater than 40%, structural models of 8 homologs of HBD-2 were
constructed. A conserved pattern of electrostatics and dynamics was observed across 6 of the
examined defensins; models backed by energetics suggest that the defensins in these 6 organisms
are characterized by dimerization-linked enhanced functional potentials. In contrast, dimerization
is not energetically favoured in the sheep, goat and mouse defensins, suggesting that they function
efficiently as monomers.
Conclusion: β-defensin 2 from some mammals may work as monomers while those in others,
including humans, work as oligomers. This could potentially be used to design human defensins that
may be effective at lower concentrations and hence have therapeutic benefits.
Background
Antimicrobial peptides (AMPs) are important compo-
nents of the innate immunity of a wide range of organ-
isms and present the first line of defence against invading
microorganisms. Typically cationic, the peptides act
against bacteria, fungi, and viruses through mechanisms
involving membrane disruption or pore formation lead-
ing to leakage of cell content and destruction [1]. A major
family of AMPs found in mammals, plants and insects is
that of the defensins – small, cationic peptides containing
one or more disulfide bridges. The human defensins are
30–45 amino acids in length, with three intramolecular
disulfide bonds, and are classified into the α and β types
based on the pattern of the disulfide bonds and mode of
release. The α-defensins are involved in systemic and
small intestinal host defence while the β-defensins protect
mucosal epithelia [2]. The expression of most β-defensins,
including the human β-defensin 2 (HBD-2) and the
mouse  β-defensin 3 is induced or upregulated upon
microbial infection. The human β-defensins have potent
antimicrobial activity and also attract T-lymphocytes and
immature dendritic cells as part of an inflammatory
response, thereby playing a key role in adaptive immunity
[3].
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It is postulated that cationicity, hydrophobicity as well as
the ability to oligomerize are key determinants of the
mode and intensity of action of antimicrobial peptides.
The crystal structure of human α-defensin hNP3 revealed
that it formed a dimer containing a six-stranded β-sheet
region [4]. NMR studies indicate that HNP-1 can also
form dimers or higher-order aggregates in solution [5].
The recent identification of Defr1, a covalently cross-
linked mouse peptide of the defensin family gave weight
to the idea that defensin antimicrobial activity is linked to
its ability to form stable higher-order structures [6]. The
observation of higher order structures of HBD3 by native
gel electrophoresis allowed modelling of an HBD3 dimer
mediated by noncovalent electrostatic interactions
between residues on the second β-sheet [7]. Structure elu-
cidation of HBD-2, the first human β-defensin structure
determined, gave two crystallographic forms, an
orthorhombic form comprising a dimer resulting from
noncovalent interactions of the first β-sheet of each mon-
omer (PDB: 1FD3, 1.35 Å), and a monoclinic di-octamer
formed by amide backbone interactions within the crys-
tallographic unit cell (PDB: 1FD4, 1.7 Å) [8]. The peptide
is found in solution mainly as dimers although it is likely
to form higher-order oligomers either in higher concen-
trations that are induced by pathogen attack, or in interac-
tions with the lipid membranes of the bacterial cells.
Defensins are highly cationic – mammalian defensins
carry charges ranging from +6 to +12, and yet they are rel-
atively small – 25–45 amino acids long in the case of the
mammalian mature peptides. In an attempt to under-
stand how a protein so small and highly charged can over-
come the gradient of charge-charge repulsions and
aggregate, we have begun a series of detailed investiga-
tions. Using the dimer as the simplest model of oligomer-
ization, we examine this feature from an evolutionary
perspective and perform a comparative study of HBD2
and a series of homologous defensins from 8 other mam-
mals (sequence identity greater than 40%). Based on a
multiple sequence alignment of these 8 sequences against
HBD-2, we construct structural models of the dimeric spe-
cies and then examine the dynamic consequences of these
structures through atomistic computer simulations, the
energetics of these associations and their functional impli-
cations.
Results and Discussion
The human HBD-2 possesses 7 cationic residues (2 Arg
and 5 Lys, offset by one anionic Asp), resulting in a charge
of +12 for the dimeric form. A histidine residue that is
present is neutral in the conditions examined. The
charged residues are distributed on the surface of the mol-
ecule except at the dimeric interface, which is comprised
largely of hydrophobic residues. The dimer interface,
which buries a surface area of ~818Å2, is formed between
the first β-strands of two monomers, mainly via hydrogen
bonds between the backbone atoms of Cys15, and aided
by van der Waals contacts made by the residues Pro5,
Ala13, Ile14, Cys15, His16, and Pro17 [8]. Figure 1 shows
the structure of the monomeric and dimeric structures of
HBD-2, coloured by polarity. The separation of the
charged sidechains, away from the dimerization interface
is clear. This suggests at first glance that dimerization is
driven largely by hydrophobic forces and little or no des-
olvation penalties are incurred for burying any charges.
Multiple sequence alignment of HBD-2 and its 8 homol-
ogous sequences (Table 1) reflects the evolutionary clus-
tering of the parent species, with distinct patterns of
amino acid distributions between primates, the trio of
pig-rat-cow and the remaining mouse-sheep-goat. The rat
and mouse homologs each have one residue less than the
remaining sequences, corresponding to positions within
the long loop between the first and second β-strands (refer
to Figure 1). While the mature C-terminal ends are all pos-
itively charged due to the presence of excess arginines and
lysines, HBD-2 and its primate homologs lack the addi-
tional terminal cationic residue, seen among the rest of
the organisms.
To gain structural insights into the spatial dispositions of
these residues, we have used these alignments to construct
3-dimensional atomistic models of the dimeric forms of
the 8 homologs using the program Modeller (see Meth-
ods). Further, to evaluate the accuracy of the employed
modelling protocol, we compared the monomeric form of
one of the models (pig homolog) with the corresponding
model generated using a program that specializes in gen-
erating structural models based on homology of small
disulfide-bonded proteins, the SDPMOD server [9]. The
two models superposed with a backbone root mean
squared deviation of only 0.6 Å (see Figure 2) with any
significant differences confined to the loop regions. This
suggests that the methodology we employed was robust.
Our choice of Modeller was driven by the need to build
structural models of dimers.
As expected from the alignment and the similarity of the
distribution of the cationic residues (Table 1), the overall
electrostatic potentials mapped on to the molecular sur-
faces (Figure 3) look similar in spatial disposition and yet
reflect the increasing cationicity across the species. A dis-
tribution into three classes, reflecting that seen in the
sequences, is evident: human-chimp-monkey; pig-rat-cow
and mouse-sheep-goat. Upon dimerization, this property
is seen to increase synergistically (Figure 3). What is
intriguing is that this enhancement of cationicity is not as
strong amongst the mouse, sheep and goat β-defensins.
This perhaps arises from the monomers being rich in cat-
ionic residues in these 3 cases (+10, +12, +12 for mouse,BMC Bioinformatics 2006, 7(Suppl 5):S17
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Monomeric and dimeric representations of HBD-2 Figure 1
Monomeric and dimeric representations of HBD-2. The structure of HBD-2 monomer (a) and dimer (b), taken from 
the crystal structure 1FD3 [8] shown as cartoons in rainbow colouring from N- to C-terminal, with line representations of cat-
ionic residues in blue, hydrophobic residues in orange, and anionic residues in red.
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Table 1: Multiple Sequence alignment of mammalian homologs of HBD-2.The chosen sequences from SWISSPROT have ≥ 40% sequence identity to human defensin HBD-2; Sequence 
details (Swiss-Prot id:organism): BD02_HUMAN: Homo sapiens (Hum); BD02_PANTR: Pan troglodytes (Chimp); BD02_MACMU: Macaca mulatta (Monkey); BD04_RAT: Rattus norvegicus 
(Rat); BD03_MOUSE: Mus musculus; BD01_PIG: Sus scrofa (Pig); TAP_BOVIN: Bos taurus (Cow); BD01_SHEEP: Ovis aries (Sheep); BD01_CAPHI: Capra hircus (Goat). The net charge for 
each sequence is shown in the last column. Cationic residues are shown in italics, conserved positions are indicated with "*" if they are invariant and ":" if they are of similar polarity.
Human G I G D P V T C L K SGAIC HPV F C P RRY K QIGT C GLPGT K CCKKP+ 6
Chimp G I S D P V T C L K SGAIC HPV F C P RRY K QIGT C GLPGT K CCKKP+ 6
Monkey G I G D P V T C L K NGA IC HPV F C P RRY K QIGT C GLPGT K CCKKP+ 6
Pig N I G N S V S C L R N K GVC MPG K C APK M K QIGT C GMPQVK CCKRK +9
Cow G V G N P V S C V R N K GIC VPIR C PGSMK QIGT C VGR AVK CCRKK +9
Sheep G V R N R LSC H R N K GVC VPS R C P R HMR QIGT C R GPPVK CCRKK +12
Goat G I R S RRS C H R N K GVC ALT R C P R NMR QIGT C FGPPV K CCRKK +12
Rat S I N N P I T C LTK GGVC WG-PC TGGFR QIGT C GLPR V R CCKKK +7
Mouse K INN PVSC L RKGGR C wN-R C IGNTR QIGS C GVPFLK CCKRK +10
: . :* . . * * :** *:* :**:: C h a r g eBMC Bioinformatics 2006, 7(Suppl 5):S17
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sheep and goat respectively), leading to a strong positive
potential that envelops the whole surface. Thus, the signif-
icant increase seen upon dimerization in the other species
is not seen in these 3 species because the monomeric sys-
tems in these 3 species are already highly charged. The
increase across the species does suggest that dimerization
will lead to a stronger charge-charge interaction with the
negatively charged bacterial membrane in contrast to the
membrane-monomer interactions. There is as yet no clear
understanding of how the interplay of electrostatic and
hydrophobic forces leads to oligomerization, even though
it is known to be important [10,11]. Rousseau [12]
pointed out that arginine and lysine residues function to
oppose aggregation by a combination of their charges,
which are repulsive in closely packed complexes, and their
long, flexible side-chains, which are entropically unfa-
vourable. However, HBD-2, which did not show a pro-
pensity to aggregate based on pure hydrophobic
Comparison of homology models Figure 2
Comparison of homology models.  Superposition of 3-dimensional homology models of pig defensin (Swiss-Prot: 
BD01_PIG) constructed using Modeller (in blue) and using SDPMOD (in red), revealing the overall similarity in backbone con-
formations.BMC Bioinformatics 2006, 7(Suppl 5):S17
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interactions (data not shown), does carry a large number
of hydrophobic residues and there are no cationic resi-
dues at the dimerization interface. The hydrophobic resi-
dues are well distributed throughout the sequence and
interspersed with several polar residues; this could theo-
retically reduce the tendency of β-aggregation. Experimen-
tally however, dimers are seen and this underscores again
the fine balance that coexists between opposing forces.
The dimer interface comprises a few hydrophobic residues
and also allows for backbone hydrogen bonds, e.g.
between Cys15 in HBD-2 dimer, seen in 1FD4 [8].
We subsequently carried out molecular dynamics simula-
tions on each of the dimers. The drifts from the initial
structures plateau for six dimers while those from mouse,
sheep, and goat show large increases (Figure 4a). While
there is no direct correlation between the amount of pos-
itive charge and the extent of deviation, we observe differ-
ences in the behaviours of these three relative to that of
the others. We note that the distance between the dimers,
as measured by monitoring the separation between the
centroids of the interfacial Cys residues shows stable sep-
arations for the dimers except for the three outliers
namely mouse, sheep and goat (Figure 4b; data has been
shown for the three outliers and for human and pig; the
other species essentially follow the stable pattern seen in
human and pig and hence have been omitted for clarity of
the figure). Indeed visual inspections show that the mon-
omers in these three cases drift away from each other by
the end of the simulations (Figure 5) – a clear indication
that charge-charge repulsions dominate. Examination of
the average fluctuations over the simulations reveals that
the fluctuations in mouse, sheep and goat are much larger
than in the other species – once again reflective of higher
motions arising from the dominating intramolecular
repulsions (Figure 6a, 6b).
The average dimerization energies, computed across the
10 ns simulations for each dimer, are strongly stabilizing
of the dimeric forms except in the three outliers (Figure
7a). As expected for such a highly charged system, the sol-
vation energies of the monomers are favourable; the fact
that the solvation of the dimers witnesses a synergistic sta-
bilization shows that the charges are not buried upon
dimerization (Figure 7b). However, the Coulombic repul-
sion far outweighs the gain in energy from solvation (Fig-
ure 7c) and it is the hydrophobic energy of dimerization
that really stabilizes the dimers; however, this is not the
case for the outliers, where the overall binding energy,
dominated by Coulombic repulsions, does not favour
dimerization.
We see that the three outliers are characterized structurally
by a higher density of cationic residues in the immediate
Electrostatic surfaces of defensin monomers and dimers Figure 3
Electrostatic surfaces of defensin monomers and dimers.  Electrostatic potentials, computed using GRASP [37] 
mapped on to the molecular surfaces of defensin monomers and dimers for each homolog (the potentials range from -10 kT/e 
for red to +10 kT/e for blue).
Pig
Pig
Monomer Dimer
Human BD2
Chimp
Monkey
Sheep
Goat
Monomer Dimer Monomer Dimer
Mouse
Rat
Cow
PigBMC Bioinformatics 2006, 7(Suppl 5):S17
Page 7 of 16
(page number not for citation purposes)
Atomic changes in defensin dimers Figure 4
Atomic changes in defensin dimers. (a) Root mean squared deviations of the Cα atoms of defensin dimers from their 
starting modelled structures over 10 ns of MD simulations; (b) Distance between chains in human, pig, mouse, sheep and goat 
defensin dimers, monitored as the distance between the centroids of the interfacial Cys residues over 10 ns MD simulations 
showing the drift arising from repulsive interactions in mouse, goat and sheep. The corresponding distances for other species 
not shown here follow the stable trend seen for human and pig dimers.
(a)
(b)BMC Bioinformatics 2006, 7(Suppl 5):S17
Page 8 of 16
(page number not for citation purposes)
Defensin dimer conformations during MD simulations Figure 5
Defensin dimer conformations during MD simulations.  Superposition of the structures of defensin dimers from (a) 
Human (b) Mouse (c) Sheep (d) Goat highlighting the drift between the monomers arising from charge-charge repulsions dur-
ing the MD simulations; the first (blue) and the last (pink) frames from the 10 ns simulations are shown.
(a) (b)
(c) (d)BMC Bioinformatics 2006, 7(Suppl 5):S17
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Atomic fluctuations of defensin dimers Figure 6
Atomic fluctuations of defensin dimers. RMSF plots for individual chains (A and B) of defensin dimers from (a) Human, 
Mac (Monkey), Pan (Chimp), Pig, Rat, Cow (b) Human, Goat, Sheep, Mouse, as computed for Cα atoms over 10 ns MD simu-
lations. The corresponding secondary structure schema is shown below each of the graphs.
(a)
(b)BMC Bioinformatics 2006, 7(Suppl 5):S17
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Energetics of defensin dimers Figure 7
Energetics of defensin dimers.  (a) Total computed average binding energy of defensin dimers (b) Solvation energy of mon-
omers and dimers of defensin homologs (c) Polar and nonpolar contributions to binding energy of dimers.
(a)
(b)
(c)BMC Bioinformatics 2006, 7(Suppl 5):S17
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Polar nature of defensin dimers Figure 8
Polar nature of defensin dimers. Distribution of cationic and hydrophobic residues in dimeric defensin homologs of (a) 
Mouse (Swiss-Prot: BD03_MOUSE), (b) Sheep (BD02_SHEEP) and (c) Goat (BD02_CAPHI).  The structures are represented 
as cartoons in rainbow colouring from N- to C-terminal, with line representations of cationic residues in blue and hydrophobic 
residues in orange.
(a) (b)
(c)BMC Bioinformatics 2006, 7(Suppl 5):S17
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vicinity of the putative dimerization interface (Figure 8)
when compared to HBD-2 (Figure 1). This would lead to
the large repulsions we see above disfavouring dimeriza-
tion and to the observed drift in the simulations of the
monomers away from each other.
Cationicity is typically correlated with antimicrobial activ-
ity, and dimerization or oligomerization brings about a
synergistic increase in cationicity of the peptide complex
over that of the monomer. This oligomerization may
indeed be an innate property as seen in these models, or
it may be brought about by an increase in local concentra-
tions that result as a response to some environmental con-
ditions, such as the presence of other molecules [13].
However, in the case of the defensin homologs of mouse,
sheep and goat, their high net charge may obviate the
need for dimerization for the purpose of increased charge
and hence activity. It is possible that the HBD-2 homologs
of these organisms do not form dimers and instead act in
the monomeric form against bacterial membranes. The
higher charges of certain defensins, such as the +12 net
charge of goat or sheep defensins, may reflect the patho-
gen environment of the species. A larger cationicity may
indicate the potential to combat a wider variety of bacte-
ria. Indeed, HBD-3 is the most cationic peptide among the
known human β-defensins. It is also the most potent
human β-defensin and is highly versatile in its pathogen
killing ability, acting against Gram-negative and Gram-
positive bacteria and fungi [7]. While cationicity alone is
not sufficient for antimicrobial effect, it is crucial for the
initial recognition and docking of the defensins to the
microbial membrane. The charge distribution variance
among the examined species may be indirectly related to
the environmental pathogens each species is typically
exposed to in its lifetime, knowledge of which will be use-
ful in the understanding and design of improved defensin
derivatives.
Mutating HBD-2 to increase cationicity
To test the above hypothesis, we carried out in silico muta-
tion of HBD-2 to increase the overall cationicity. Based on
the multiple sequence alignment, neutral residues in three
positions within the human model structure were
replaced with Arg (Figure 9), guided by the presence of
homologous Arg in the corresponding positions in goat
and sheep; this resulted in an overall charge of +18 for this
mutant HBD-2. The computed dimerization energies
showed that the mutant dimer was 2% less stable than the
wild type dimer. The introduction of the excess positive
charges leads to destabilized electrostatics (~50% more
than in the wild type dimer); this was offset by an almost
equal contribution from hydrophobic forces. This again
underscores the tenuous links between opposing forces
and structural dispositions of charges in proteins. But the
observation that our mutations destabilized the dimeric
species provides us with confidence that we are proceed-
ing in the right direction for the design of suitable ana-
logues.
Towards a model for peptide-membrane interaction
So how do defensins (and antimicrobial peptides in gen-
eral) disrupt bacterial membranes? Clearly the process
involves recognition, assembly and association (in some
order), followed by one or more mechanisms whereby the
defensin disrupts the regular structure and function of the
membrane [1]. One suggestion was that the membrane
interaction was independent of the peptide's secondary
structure and involved the overall spatial arrangement of
polar and hydrophobic residues [14]. Further, given the
amphipathic nature of membranes, the initial steps of
membrane association and the final alignment and local-
ization of the peptides within membranes would also
depend on some combination of hydrophobic and elec-
trostatic interactions [15]. This leads to one of the more
commonly accepted models, the carpet model, which
postulates that the peptides, at sufficiently high concen-
trations, aggregate into micelles and disrupt the mem-
brane [16]. While direct evidence of peptide aggregation
in the membrane has been lacking, a solid-state NMR
study yielded a model of protegrin-1 aggregation in lipid
bilayers [17]. Thus, it is possible that higher order oligom-
ers of HBD-2 transiently form upon association with the
membrane, although such a phenomenon is yet to be
observed through biophysical methods.
It is known that unstructured clusters of basic residues on
proteins can produce strong localized electrostatic poten-
tials, which can enhance their attraction to anionic mem-
branes [18]. These lead to accumulation/lateral
organization of the proteins at the membrane surfaces
[19] and can mediate the self-promoted uptake of
defensins across the cell wall followed by interaction with
the anionic bacterial cytoplasmic membrane [20]. The
HBD-2 structure possesses a highly positively-charged
"tail" region. Upon dimerization, the tails of both mono-
mers project from the same end of the dimer, resulting in
a claw-like appearance (Figure 10). It is possible that the
monomer or even the dimer employs this projecting cati-
onic region to make initial contact with, or even a prehen-
sile grasp of, the outer edge of the bacterial membrane.
This could be followed by reorientations of the HBD-2
molecules, possibly in association with other HBD-2 mol-
ecules, to allow the hydrophobic residues to penetrate the
lipid bilayer. The multiple sequence alignment of HBD-2
and related β-defensin sequences (Table 1) shows a con-
servation of cationic residues in this tail region. Although
the actual number of these cationic residues varies
between species and type of defensin, it does point
towards the possibility of such an occurrence.BMC Bioinformatics 2006, 7(Suppl 5):S17
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This is the very first study to our knowledge which has
looked at the propensity of defensins to oligomerize and
the concomitant functional relevance. While there is very
little experimental data to date on the kinetics or energet-
ics of such processes in defensins, a better understanding
of the mechanisms underlying the broad-spectrum bacte-
rial killing by antimicrobial peptides remains of para-
mount interest. In view of the growing resistance of
pathogens to conventional antibiotics, this would help
accelerate developments of new potent antibiotics. We
hope that this kind of study will lead to further and more
detailed experimental and theoretical investigations on
the mode of action of antimicrobial peptides.
Conclusion
We have used the dimer as the simplest model of oli-
gomerization for a comparative study of the dimerization
and relative cationicity of defensin HBD-2 and modelled
homologs from 8 other mammals. A clear clustering of
overall cationicity and potential to oligomerize was seen.
While the defensins from 6 species showed a propensity
to dimerize, the dimerization potentials of those from
mouse, sheep and goat tend to disfavour dimeric assem-
blies. This suggests that either these outlier defensins act
in the monomeric form against bacterial membranes or
that they function as much higher oligomeric species; the
high charge densities tend to suggest that their mono-
meric forms are the functional units.
Structural model of mutant HBD-2 (Hum-mut) Figure 9
Structural model of mutant HBD-2 (Hum-mut). The chains are each displayed in rainbow colouring from N- to C-ter-
minus. All cationic residues are shown in blue, and the positions of the Arg mutations are highlighted in stick representation.BMC Bioinformatics 2006, 7(Suppl 5):S17
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Methods
Using the mature peptide sequence of HBD-2 as a query
in Blastp [21], several hits across species were obtained.
The top 20 hits were aligned against the query sequence in
a multiple sequence alignment using ClustalX [22]. We
chose the top sequences (≥ 40% sequence identity), orig-
inating from 8 unique species for further study.
Monomer and dimer models of eight homologous mam-
malian sequences of HBD-2 were built using MODELLER
Cationic claw of defensin dimers Figure 10
Cationic claw of defensin dimers. The HBD-2 structure (from 1FD3) possesses a highly cationic "tail" region, and upon 
dimerization, the pair of tails project from the same end of the dimer, resulting in a claw-like appearance.
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[23] based on the structure of a dimeric complex of HBD-
2 (chains C and D of PDB: 1FD3, X-ray crystal structure
resolved to 1.35 Å) [8]. The side-chains were built and
optimized using SCWRL [24]. Structural representations
were visualized using Pymol [25] and simulations were
viewed using VMD [26].
The solvation energies of the monomeric and dimeric
forms of each defensin species examined was calculated
by solving the non-linearized form of the PB equation in
parallel with the Adaptive Poisson-Boltzmann Solver
(APBS) [27].
Molecular dynamics (MD) simulations were performed
using the AMBER 8.0 package and parm99 force field [28].
The initial structures were solvated with three- point trans-
ferable intermolecular potential (TIP3P) water molecules
[29] and appropriate number of Chloride ions in a rectan-
gular box to neutralize the system; the box dimensions
ensured that any protein atom was at least 8 Å away from
the wall of the box. After energy minimization, MD simu-
lations were performed for 130 ps at constant temperature
(300 K) and pressure (1 atm) with periodic boundary con-
ditions, particle-mesh Ewald summation, and a 1-fs time
step to heat and equilibrate the system. This was followed
by production runs of 10 ns duration for each simulation.
Structures were saved every 10 ps for analysis. The relative
binding energies for dimer formation were computed
using the MM-PBSA module of AMBER 8.0, employing
molecular mechanics and a continuum solvent model
[30]. This method calculates a gas-phase contribution to
binding using an all-atom force field and incorporates the
influence of solvent via the Generalized Born (GB) sol-
vent models [31,32].
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